Tenpoint Therapeutics Secures $70M for Ocular Regenerative Medicine
Tenpoint Therapeutics, a biotechnology company based in Cambridge, UK, has recently secured $70M in Series A funding. The funding round was backed by several investors, including British Patient Capital, F-Prime Capital, Sofinnova Partners, Qiming Venture Partners USA, Eight Roads, and the UCL Technology Fund. With this funding, Tenpoint aims to advance its regenerative medicine platform, which focuses on developing engineered cell-based therapies and in vivo reprogramming techniques.
The company's primary goal is to restore vision for individuals suffering from degenerative ocular diseases by replacing multiple cell types that are lost due to inherited and age-related conditions.
Led by Eddy Anglade, MD, who serves as the CEO, Tenpoint has established itself as a committed biotechnology company in the field of regenerative medicine. The company's regenerative medicine platform has vast potential in combating ocular diseases caused by both age-related factors and genetic inheritances.
Tenpoint was founded by a team of renowned experts from various institutions, including Moorfields Eye Hospital, University College London Institute of Ophthalmology, Institut de la Vision in Paris, and the University of Washington. These scientific founders have made significant contributions to the development of engineered cell-based therapeutics and have conducted translational research to establish proof-of-concept. Based on their groundbreaking achievements, Tenpoint is now actively working on generating specialized ocular cell types both ex vivo and in vivo.
They've invested in Tenpoint Therapeutics
Get to know these Biotech investors
| # | Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|---|
1 |  British Patient Capital | 10 investment(s) investment(s) | 25 contacts contacts | |||
2 |  Sofinnova Partners | 9 investment(s) investment(s) | 29 contacts contacts | |||
3 |  Qiming Venture Partners USA | 1 investment(s) investment(s) | 7 contacts contacts | |||
4 |  UCL Technology Fund | 5 investment(s) investment(s) | more info |
Click here for a full list of 6,528+ startup investors in the UK